Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Trump vs. Harris: How Could the US Election Affect the Gold Price?

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

A Guide to Investing in Physical Gold (Updated 2024)

How Will the US Election Affect the Crypto Industry?

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Should You Invest in Silver Bullion? (Updated 2024)

7 Biggest Lithium-mining Companies in 2024

Trending Press Releases

Argentina Lithium Announces Receipt of Drill Permit for the Paso de Sico Property at its Rincon West Lithium Project

Astral’s Group Gold Mineral Resource Increases to 1.46Moz with Updated Feysville MRE

Ashburton Mineralisation Expands as Project Delivers Wide and High-grade Uranium Drill Results

Brunswick Exploration Discovers Greenland's First Spodumene Pegmatite in Major Evolved Pegmatite Field

Vertex Minerals Limited Quarterly Activities Report

Mawson Finland: Gold, Cobalt Exploration in Lapland Region, Northern Finland

More Press Releases
Trending Companies

Controlled Thermal Resources

Falco Resources

FPC:CC

Red Metal Resources

RMES:CC

Adisyn

AI1:AU
More Companies
Trending Reports

2024 Lithium Market Outlook

2024 Gold Outlook Report

2024 Copper Outlook Report

Rare Earths Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

BELLUS Health

TSX:BLU
Press Releases

BELLUS Health Announces Meeting Updates

BELLUS Health Reports Q3 Financial Results

Bellus Health Launches US$60 Million Public Offering and Files to List Shares on NASDAQ

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, a P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.

Interactive Chart

×